Tamoxifen

Revision as of 18:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Tamoxifen": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Synonyms / Brand Names:Apo-Tamox, Citofen, Crisafeno, Diemon, Gen-Tamoxifen, Istubol, Kessar, Noltam, Nolvadex, Nolvadex-D, Nourytam, Novo-Tamoxifen, Oncomox, PMS-Tamoxifen, Retaxim, Tamizam, Tamofen, Tamone, Tamoxasta, Tamoxen, Tamoxifen citrate, Valodex, Zemide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

For patients with breast cancer, the recommended daily dose is 20-40 mg. Dosages greater than 20 mg per day should be given in divided doses (morning and evening). For patients with Ductal Carcinoma in Situ (DCIS), the recommended dose is Tamoxifen citrate tablet 20 mg daily for 5 years.

WARNING: For Women with Ductal Carcinoma in Situ (DCIS) and Women at High Risk for Breast Cancer: Serious and life-threatening events associated with Tamoxifen in the risk reduction setting (women at high risk for cancer and women with DCIS) include uterine malignancies, stroke and pulmonary embolism.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Tamoxifen

Return to top

Publication Resources

Most Recent Articles on Tamoxifen

Review Articles on Tamoxifen

Articles on Tamoxifen in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Tamoxifen

Return to top

Trial Resources

Ongoing Trials with Tamoxifen at Clinical Trials.gov

Trial Results with Tamoxifen

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Tamoxifen

Cochrane Collaboration on Tamoxifen

Cost Effectiveness of Tamoxifen

Return to top

Media Resources

Powerpoint Slides on Tamoxifen

Images of Tamoxifen

Podcasts & MP3s on Tamoxifen

Videos on Tamoxifen

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Tamoxifen

Discussion Groups on Tamoxifen

Patient Handouts on Tamoxifen

Blogs on Tamoxifen

Tamoxifen in the News

Tamoxifen in the Marketplace

Return to top

International Resources

Tamoxifen en Español

Return to top


Adapted from the FDA Package Insert. Template:WS Template:WH